Radium-223 for Patients with Metastatic Castration-Resistant Prostate Cancer with Asymptomatic Bone Metastases Progressing on First-Line Abiraterone Acetate or Enzalutamide: A Single-Arm Phase II Trial.
European Journal of Cancer（2022）
Key words
Radium-223,AR-V7,Bone metastases,Metastatic castration-resistant prostate cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined